Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity was posted on August 27, 2013. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Development of a mouse model for Merkel Cell Carcinoma

Awarded
NCI-130119-TKFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 541380
New
SLED
Fire Flow Testing Services
Solicitation # 121589
WSSC Water is soliciting bids for Fire Flow Testing Services to support the planning, locating, inspection, and testing of approximately 46,000 fire hydrants and associated water distribution components across various pressure zones in Maryland. The scope of work includes performing fire flow tests, hydrant and valve inspections, managing water shutdowns, and implementing traffic control for residential, county, and state roads. The contract is structured with a one-year base term and four optional one-year extensions. Award will be made to a single, responsive, and responsible bidder based on the lowest total price, provided they meet strict minimum qualifications, including five years of prime experience in fire flow testing, the ability to deploy at least two simultaneous crews, and the employment of at least one crew member with a Maryland Water Distribution System Operator D-1 license. Bidders must submit a comprehensive set of documentation via the eProcurement portal by November 30, 2026, including a safety and health program questionnaire, a certificate of insurance, and various certifications regarding non-discrimination and Iran investment activity. Technical requirements include the submission of a detailed QA/QC plan and an equipment list featuring specialized tools like Pitot gauges and dechlorination equipment. The contract emphasizes compliance with AWWA and MDE standards, specifically regarding the discharge of chlorinated water. Notably, the agreement excludes the COVID-19 pandemic from Force Majeure claims and requires strict adherence to security background investigations for accessing sensitive facility plans. Payment is processed via ACH or procurement credit card within 30 days of accepted delivery, with a potential award factor based on prompt payment discounts.
Utility Services Department

POSTED

about 16 hours ago

DEADLINE

in about 1 month

AI Contract Overview

Show more

The National Cancer Institute Dermatology Branch intends to award a firm fixed price contract for the development of a mouse model for Merkel Cell Carcinoma. The project aims to study the effects of Merkel Cell Polyomavirus large T antigen using an inducible system to better understand the mechanisms of this aggressive disease. The scope of work involves the creation of two specific mouse models, requiring the use of proprietary TARGATT technology to ensure efficient gene insertion into a defined locus. The selected contractor will be responsible for DNA pronuclear microinjection into the C57BL6 mouse strain, the generation of specific constructs and integrase, and the ongoing breeding, housing, and genotyping of the animals. The period of performance is one year from the date of award. While the NCI plans to procure these services from Applied Stem Cell on a sole source basis, interested parties may submit proposals by September 10, 2013.

General Info

Agency

N/A

Contract Value

$33,100

NAICS

541380 - Testing Laboratories and Services

Place of Performance

MD, USA

Set-Aside

NONE

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseAwarded
Posted

Presolicitation

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts1 person available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts

Full Description

Show more
Title: Development of a mouse model for Merkel Cell Carcinoma Document Type: Presolicitation Notice Solicitation Number: NCI-130119-TK Proposed Posted Date: August 27, 2013 Proposed Response Date: September 10, 2013 Classification Code: B-Special studies and analysis NAICS Code: 541380- Testing laboratories Business Size Standard: $14 Million Description The National Cancer Institute (NCI) Dermatology Branch plans to procure on a sole source basis the services to develop a mouse model of Merkel Cell Carcinoma from Applied Stem Cell at 1165 O'Brien Drive, Suite A Menlo Park, CA 94025. The products herein are being procured in accordance with the simplified acquisition procedures as authorized by FAR Part 13.106-1 (b) (1). The North American Industry Classification System code is 541380 and the business size standard is 14 million. Only one award will be made as a result of this solicitation. This will be awarded as a firm fixed price type contract. Period of Performance: One year from the time of award. The NIH, NCI, Dermatology Branch, Cutaneous Development and Carcinogenesis Section, work on Merkel Cell Carcinoma as well as studying normal Merkel Cell development and Merkel Cell Stem cells in skin. Mouse models are powerful means of studying skin tissue, and the laboratory has many mouse models to study normal Merkel Cell development in skin. The two mice NCI would like to have generated will be very useful in studying Merkel Cell Carcinoma. Specifically, by crossing these mice NCI will be able to study the effect of Merkel Cell Polyomavirus large T antigen under the control of the Cytokeratin 18 promoter in an inducible system. This system will be important for further understanding of the mechanisms involved in Merkel Cell Polyomavirus T antigen driven cancers and will provide a model for further study of pathways involved in the development of this aggressive disease. The purpose of this acquisition is to develop a mouse model of Merkel Cell Carcinoma which is critical for further study of the pathways involved in the development of this disease. This project requires the use of TARGATT technology. TARGATT, which is proprietary technology to Applied Stem cell, was developed specifically for introducing gene(s) of interest into mammalian cell lines. The unique advantage of this system is that any gene can be inserted efficiently into a defined, transcriptionally-active locus with high gene expression in a single copy fashion. Tasks shall include: - The contractor shall perform DNA pronuclear microinjection of our BAC clone into the C57BL6 mouse strain (MOUSE #1 KI/KO PROJECT (BAC) ) - The contractor shall provide breeding, housing, care, and genotyping for this BAC mouse project - The contractor shall make a TARGATT vector using a TetO-oncogene that will be provided by our lab - The contractor shall generate AttB-TetO-Oncogene construct, and confirm the construct by enzyme digestion and sequencing, as well as purifying the construct and verifying its purity. (MOUSE #2 TARGATT PROJECT) - The contractor shall generate TARGATT integrase - The contractor shall do TARGATT DNA pronuclear microinjection into the C57BL6 mouse strain - The contractor shall provide animal housing, care, and genotyping during the course of this project. B. Reports : At the completion of each milestone, the contractor shall send a written report to the Brownell Laboratory. In addition, the contractor shall communicate weekly via email/phone to maintain continuity. For Mouse #1 KI/KO project (BAC) the report shall include Mouse generation steps (client is providing the targeting vector construct to ASC). For Mouse #2 TARGATT project, the reports shall include: - DNA construct design, schematic map, sequence and restriction enzyme digestion results; - Generation of Integrase mRNA, microinjection, embryo implantation and Quality Control; - Generation of transgenic mouse/mice and genotyping data This is not a solicitation for competitive quotations. However, if any interested party, especially a small business, believes they can meet the above requirement, they may submit a proposal. All information furnished must be in writing and must contain sufficient detail to allow the NCI to determine if it can meet the above unique specifications described herein. The proposal must be received at the NCI Office of Acquisitions on or before 11:00 AM EST on September 10, 2013. All responses and questions must be in writing and can be faxed +1 (555) 000-0000 or emailed to Tiffany Kittrell, Contract Specialist at contact@example.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. In order to receive an award, contractors must have valid registration and certification in the Central Contractor Registration (CCR) and the Online Representations and Certifications Applications (ORCA) through sam.gov. No collect calls will be accepted. Please reference solicitation number NCI-130119-TK on all correspondences.

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS